LOXO ONCOLOGY INC's ticker is LOXO and the CUSIP is 548862101. A total of 51 filers reported holding LOXO ONCOLOGY INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $390,793,000 | -14.3% | 2,789,978 | +4.5% | 0.02% | 0.0% |
| Q3 2018 | $456,119,000 | +10.1% | 2,670,023 | +11.8% | 0.02% | +5.9% |
| Q2 2018 | $414,337,000 | +69.9% | 2,388,388 | +13.0% | 0.02% | +54.5% |
| Q1 2018 | $243,911,000 | +46.9% | 2,114,163 | +7.2% | 0.01% | +57.1% |
| Q4 2017 | $166,079,000 | +26.6% | 1,972,919 | +38.6% | 0.01% | +16.7% |
| Q3 2017 | $131,157,000 | +78.8% | 1,423,761 | +55.7% | 0.01% | +50.0% |
| Q2 2017 | $73,351,000 | +137.7% | 914,719 | +24.7% | 0.00% | +100.0% |
| Q1 2017 | $30,856,000 | +87.1% | 733,248 | +42.8% | 0.00% | +100.0% |
| Q4 2016 | $16,488,000 | +24.7% | 513,411 | +1.6% | 0.00% | 0.0% |
| Q3 2016 | $13,225,000 | +14.3% | 505,141 | +1.2% | 0.00% | 0.0% |
| Q2 2016 | $11,573,000 | +52.6% | 499,283 | +80.0% | 0.00% | – |
| Q1 2016 | $7,583,000 | +5.5% | 277,382 | +9.8% | 0.00% | – |
| Q4 2015 | $7,186,000 | +161.6% | 252,585 | +60.7% | 0.00% | – |
| Q3 2015 | $2,747,000 | -14.2% | 157,159 | -11.4% | 0.00% | – |
| Q2 2015 | $3,200,000 | +479.7% | 177,478 | +300.1% | 0.00% | – |
| Q1 2015 | $552,000 | +31.4% | 44,357 | +24.2% | 0.00% | – |
| Q4 2014 | $420,000 | – | 35,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|